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Abstract
Background: Around 70% neonatal deaths occur in low birth weight (LBW) babies. Globally, 15% of babies are
born with LBW. Kangaroo Mother Care (KMC) appears to be an effective way to reduce mortality and morbidity
among LBW babies. KMC comprises of early and continuous skin-to-skin contact between mother and baby as
well as exclusive breastfeeding. Evidence derived from hospital-based studies shows that KMC results in a 40%
relative reduction in mortality, a 58% relative reduction in the risk of nosocomial infections or sepsis, shorter
hospital stay, and a lower risk of lower respiratory tract infections in babies with birth weight <2000 g. There has been
considerable interest in KMC initiated outside health facilities for LBW babies born at home or discharged early.
Currently, there is insufficient evidence to support initiation of KMC in the community (cKMC). Formative research in
our study setting, where 24% of babies are born with LBW, demonstrated that KMC is feasible and acceptable when
initiated at home for LBW babies. The aim of this trial is to determine the impact of cKMC on the survival of these
babies.
Methods/design: This randomized controlled trial is being undertaken in the Palwal and Faridabad districts in the
State of Haryana, India. Neonates weighing 1500–2250 g identified within 3 days of birth and their mothers are being
enrolled. Other inclusion criteria are that the family is likely to be available in the study area over the next 6 months,
that KMC was not initiated in the delivery facility, and that the infant does not have an illness requiring hospitalization.
Eligible neonates are randomized into intervention and control groups. The intervention is delivered through home
visits during the first month of life by study workers with a background and education similar to that of workers in the
government health system. An independent study team collects mortality and morbidity data as well as anthropometric
measurements during periodic home visits. The primary outcomes of the study are postenrollment neonatal mortality
and mortality between enrollment and 6 months of age. The secondary outcomes are breastfeeding practices; prevalence
of illnesses and care-seeking practices for the same; hospitalizations; weight and length gain; and, in a subsample,
neurodevelopment.
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Discussion: This efficacy trial will answer the question whether the benefits of KMC observed in hospital settings
can also be observed when KMC is started in the community. The formative research used for intervention development
suggests that the necessary high level of KMC adoption can be reached in the community, addressing a problem that
seriously constrained conclusions in the only other trial in which researchers examined the benefits of cKMC.
Trial registration: ClinicalTrials.gov identifier: NCT02653534. Registered on 26 December 2015 (retrospectively
registered).
Keywords: Community-initiated Kangaroo Mother Care, Low birth weight babies, Mortality
Background
Globally, around 15% of newborns are born with low
birth weight (LBW) as a result of preterm birth or intra-
uterine growth retardation or both, and up to 70% of
neonatal deaths occur in these infants [1]. In India, 28%
of babies are born with LBW, and recent data derived
from a study setting showed that 24% of babies are born
with LBW [2, 3]. The causes of death in LBW neonates
include respiratory and brain immaturity, hypothermia,
hypoglycemia, and infection [1]. In addition, LBW in-
fants are at high risk of impaired growth and develop-
ment [4]. A recent review of available interventions
suggested that breastfeeding, hygiene, antenatal cortico-
steroids to prevent preterm birth complications, case
management of suspected infections, and hospital care
of small babies that includes Kangaroo Mother Care
(KMC) are the most effective interventions for impro-
ving survival of LBW infants [5].
KMC is an effective way to reduce mortality among
LBW babies. It helps to meet babies’ needs for warmth,
breast milk, protection from infection, safety, and love
[6]. KMC as defined by the World Health Organization
(WHO) is care of preterm and LBW infants where the
mother keeps the baby in skin-to-skin contact (SSC) on
her chest between her bare breasts continuously until
the baby no longer wants to stay in that position, and
exclusively breastfeeds the baby [6]. Authors of a recent
Cochrane review reported a 40% relative reduction in
mortality with this intervention compared with standard
care in hospitalized infants with a birth weight <2000 g
[7]. The review showed a 58% relative reduction in the
occurrence of nosocomial infections or sepsis at dis-
charge or at 40–41 weeks corrected gestational age, a
shorter duration of hospital stay, and lower incidence of
respiratory tract infections.
Prolonged SSC has been shown to provide effective
thermal control for preterm and LBW babies. The re-
view cited above showed a 76% relative reduction in the
occurrence of hypothermia by hospital discharge or 40–41
weeks corrected gestational age [7]. KMC has been re-
ported to increase the prevalence and duration of breast-
feeding and exclusive breastfeeding, also in India [8–15].
A meta-analysis showed that infants receiving KMC
gained more weight per day by the time of discharge from
the birth facility and had a larger head circumference at 6
months of corrected gestational age than did control sub-
jects [7]. Heart rate, respiratory rate, oxygenation, blood
glucose, sleep patterns, and behavior observed in preterm/
LBW infants held skin-to-skin are either similar to or bet-
ter than in infants separated from their mothers [16–18].
The level of stress, indicated by salivary cortisol, was
found to be lower in newborn infants held in SSC [19].
Cognitive development seemed to improve with KMC
[20]. Various studies have shown that KMC may reduce
maternal anxiety and improve self-efficacy and mother-
child bonding, which may result in more effective new-
born care [21–26].
The evidence summarized above comes from studies
where KMC was initiated in the hospital [27]. There has
been considerable interest in KMC initiated outside
health facilities for LBW babies born at home or dis-
charged early from health facilities. There is only one
published randomized controlled trial of community-
initiated Kangaroo Mother Care (cKMC) [28]. In that
cluster randomized controlled trial conducted in
Bangladesh, cKMC was promoted for all newborns, re-
gardless of birth weight. In intervention clusters, about
77% of infants received any SSC, with only 24% receiving
any SSC for >7 h/day in the first 2 days of life. The study
reported no overall difference in mortality between the
intervention and control groups (OR 1.06, 95% CI 0.76–
1.48). Although there was a reduction in mortality
among babies with birth weight ≤2000 g (OR 0.37, 95%
CI 0.16–0.86), mortality was higher (OR 1.31, 95% CI
0.94–1.82) among infants with missing birth weights
(about 40% of all newborns, and 65% of all deaths had a
missing birth weight). The authors concluded that there
was insufficient evidence to support implementing cKMC.
In most developing countries, only a small proportion
of LBW infants can be hospitalized for care. In these set-
tings, a large proportion of deliveries still take place at
home, and even if born in facilities, newborns are dis-
charged early. It is therefore crucial to evaluate cKMC in
a well-conducted efficacy study.
We are undertaking a randomized controlled trial to
evaluate the impact of cKMC on newborn survival. In
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preparation for this study, we undertook intensive for-
mative research to develop the cKMC intervention pack-
age to assure ourselves that there would be a high rate
of cKMC adoption by families.
This paper describes an efficacy trial in which the pri-
mary objective is to determine the impact of promoting
cKMC for LBW infants on postenrollment neonatal
mortality and on mortality from enrollment up to 6
months of age. The secondary objectives of the study are
to determine the impact of promoting cKMC on the
following:
– Proportion of infants exclusively breastfed at 1 and 3
months of age
– Weight, length, and head circumference gain at 1, 3,
and 6 months of age
– Incidence of infections and hospitalizations in the
neonatal period and between 1 month and 5 months
of age
– Recognition of illness and early care seeking by the
family from appropriate sources
– In a subsample, neurodevelopment at 6 and 12
months of age
Methods/design
The protocol has been prepared according to the Standard
Protocol Items: Recommendations for Interventional Trials
(Additional file 1).
Study design
The study is a randomized controlled trial. The first 550
infants enrolled are also enrolled in a study whose aim is
to assess the impact of the intervention on neurodeve-
lopment (ClinicalTrials.gov identifier NCT02631343). In
the formative research conducted prior to trial initiation,
qualitative research methods such as in-depth inter-
views, focus group discussions, and observations were
used to ascertain practices around birth and to assess
the feasibility and acceptability of cKMC. A prototype
intervention package and delivery strategy were de-
signed, and household trials were conducted to ascertain
adoption rates among mothers of LBW babies [29].
Study setting
The study is ongoing in Palwal and Faridabad districts in
the State of Haryana, India. In this region with a population
of around 2 million, the median family size is 6 (IQR 4–9)
[3]. The birth rate is 25.6/1000 [30]. Forty percent of deliv-
eries occur at home, and 24% of all babies are born with
LBW (<2500 g) [3]. The common occupations for men are
employment in nearby factories or other commercial enter-
prises (38%), daily wage laborers in construction (20%), self-
employment (22%), farming (10%), and government service
(5%); 5% are unemployed. The median number of years of
schooling is 8 for men (IQR 5–11) and 5 for women (IQR
0–8). Over 40% of women have never been to school,
and almost all (95%) women do not work outside the
home for an income [3].
The common sources of drinking water are hand
pumps (approximately 40%), piped water supply (ap-
proximately 30%), public taps (approximately 20%), and
others (10%). Around 60% of the population uses open
fields for defecation. A high proportion (92%) of families
has electricity in their homes. Care of ill children is most
often (60%) sought from private practitioners within and
outside the villages.
The government-owned primary health center (PHC)
is the most basic structural and functional unit of the
health system. Apart from regular medical treatment,
PHCs focus on maternal-child health promotion, includ-
ing family planning as well as safe water supply access
and basic sanitation. A PHC caters to a population of
approximately 30,000. Under each PHC, there are 4 to 5
subcenters, each of which caters to a population of
approximately 5000. Each subcenter is managed by a fe-
male health worker commonly known as the auxiliary
nurse midwife (ANM) [31]. Her role encompasses pro-
motion of preventive and curative health services, which
include family-planning services, nutrition education,
health education, collaborative services for improvement
of sanitation, immunization for control of communicable
diseases, treatment of minor ailments and first aid in
emergencies, organizing health days in the community,
and working closely with Accredited Social Health
Activists (ASHAs) [31]. Each ANM is supported by
four or five ASHAs, who are the first contact persons
between the community and the health system (http://
nrhm.gov.in).
ASHAs are community health workers employed by
the government and cater to a population of approxi-
mately 1000. They are local women trained to act as
health educators and promote universal immunization,
timely referral, and escorting women and children for
reproductive and child health and other health care pro-
grams in their communities [32].
Besides these workers, Anganwadi workers (AWWs)
operate from Anganwadi centers (AWCs). An AWC is a
government-sponsored child care and maternal care
center in India. It caters to children in the 0–6 years
age group. This center is the focal point for delivery of
all services under the Integrated Child Development
Services program to children and women (http://icds-
wcd.nic.in/icds/icds.aspx). One AWW caters to a popu-
lation of approximately 1000.
Study participants
We are enrolling babies between 1500 and 2250 g be-
cause our formative research revealed that most babies
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weighing more than 2250 g did not want to remain in
the KMC position and tried to wriggle out as early as
4–5 days after initiating KMC. Babies weighing <1500
g are often unstable and have feeding and breathing
difficulties, and including them may raise safety con-
cerns, especially in a study that is being conducted in
the community. Because in this study KMC is ini-
tiated at home, and because two-thirds of deliveries
take place in hospitals where the recommended prac-
tice is to discharge mothers after 48 h, the window
for enrolling babies is within 3 days of birth.
Inclusion and exclusion criteria
All LBW babies (1500–2250 g) and their mothers are
screened within 3 days of delivery. Babies born at home
and babies born in health facilities are included if KMC
was not initiated in the facility. Infants who are unable
to feed, have breathing problems, have gross congenital
malformations, or are less than normally active (i.e., ba-
bies whose movements are less than usual or who do
not wake up with stimulation or during assessment on
the day of the visit) are referred to hospitals. Those
mothers intending to move away over the next 6 months
or who do not consent to participate are also excluded.
Sample size
Approximately 12% of infants in the study area weigh
between 1500 g and 2250 g [3]. Assuming a postenroll-
ment neonatal mortality risk of 42 per 1000 in this birth
weight group, and accounting for 10% attrition, we need
to enroll a total of 10,500 infants (with 95% confidence
and 90% power) to detect a 30% relative mortality reduc-
tion among neonates. We expect that this will also en-
able us to detect impact on mortality from enrollment
until 6 months of age. The data safety and monitoring
committee (DSMC) will review the sample size when
about half of the enrollments have been completed, with
the possibility of adjusting the sample size.
Identification of pregnancies by the surveillance team
Surveillance workers conduct door-to-door surveys in
the study areas. Surveys are redone at least quarterly.
The details of all pregnant women are communicated to
a study coordinator who allocates them to the relevant
worker for follow-up.
Pregnancy follow-up, screening, and enrollment
All identified pregnancies are allocated to the pregnancy
follow-up and screening and enrollment (PSE) team.
Each PSE team member covers a fixed geographical area
comprising 3500–5000 households. These workers keep
in touch with pregnant women through phone contacts
or home visits (if phone calls are unsuccessful) monthly
in the initial months, twice weekly in the third trimester,
and daily as the time of delivery approaches. The study
is explained to families, and they are asked to inform the
study team when the woman delivers. Outcomes of
pregnancies—abortions, stillbirths, and live births—are
documented. If a woman delivers at home, the team
visits the household as soon as possible after delivery
and weighs the infant. Workers keep in touch with fa-
milies of women who deliver in the hospital, and women
are visited as soon as possible after discharge. Prior to
screening, consent for participation is taken. If the
weight of the baby is <1800 g, families are counseled
to visit health facilities as mandated by the Indian
government [33].
Infants who are identified as being ill are referred, and
contact with the family is maintained. Hospitalization is
facilitated by putting the family in touch with the ASHA
in their area. The baby is screened for enrollment when
discharged from the hospital if still within the 3-day en-
rollment window.
Randomization, allocation, and masking
The randomization list was prepared using random per-
muted blocks of variable block size by an offsite statisti-
cian from the WHO in Geneva who is not otherwise
involved with the trial. Once an infant meets the inclu-
sion criteria, has no exclusion criteria, and the family
consents to participation, the PSE worker calls the co-
ordinator in charge for allocating the participant an
identification number. The coordinator opens a sequen-
tially numbered, opaque sealed envelope (SNOSE) next
in serial order and communicates the participant identi-
fication number to the worker. These procedures are
identical for intervention and control participants, and
PSE workers are not aware of the group allocation.
For twins, triplets, or multiple children (i.e., children
of parents living in the same household enrolled earlier
and randomized to the intervention group), the same
intervention is allocated, and the participant identifica-
tion number is suffixed with letters B and C, respect-
ively. Similarly, if the mother has another eligible baby
from a subsequent pregnancy, the same identification
number is allocated, and a suffix is added. Only if the
previously enrolled infant is in the control group is a
new SNOSE opened. This strategy is being followed to
give the second infant a chance of getting the intervention.
Home visits by ASHAs under the national program
Under the national program, all infants (in the interven-
tion or control group) are to be visited on days 1, 3, 7,
14, 21, 28, and 42 for counseling on essential newborn
care, identification of illnesses, and referral of ill infants
[34]. The national program also envisages that additional
visits will be required for babies born with LBW. The
visits by the team that supports the mother to do KMC
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have also been scheduled with what is visualized in the
national program kept in mind (days 1, 2, 3, 5, 7, 10, 14,
21, and 28).
Intervention delivery
The coordinator informs the intervention delivery team
whenever an infant is allocated to the intervention
group. This team comprises workers with educational
and work experience backgrounds similar to those of
government ANMs and ASHAs, and therefore they are
designated as study ANMs and study ASHAs. A pair of
workers makes the first visit to explain KMC and sup-
port the mother to do it. KMC is promoted using the
local term identified during formative research—chaati
se chipkana—or “sticking the baby to the chest.” The
team uses photographs, helps the mother place the baby
in the KMC position, and observes breastfeeding. The
mother is advised to do SSC in the position in which she
is most comfortable: semireclining or supine. Family
members, including husband and mother-in-law or
other relatives in the home, are also taught the proce-
dure and encouraged to do SSC during the periods when
the mother is not doing so or by helping with the house-
hold work so that the mother is free to be with the baby.
As described above, the visits are made daily for the
first 3 days, on days 5 and 7, twice in week 2, and once
each in weeks 3 and 4. ANMs and ASHAs visit together
on the first 3 days. Subsequently, the ANM visits if the
mother is having problems in doing KMC or needs
counseling for breastfeeding. Visits end at 28 days or
earlier if the baby no longer wants to be kept in KMC
position as evidenced by the baby trying to wriggle out.
At each visit, the ASHA documents how much KMC
has been given since the last visit.
Outcome ascertainment
Enrolled infants in both the intervention and control
groups are visited by an independent outcome ascertain-
ment team. An attempt is made to keep the team
blinded as far as possible to whether the baby belongs to
the intervention or control group. Weight, length, and
head circumference are measured by a pair of workers.
A baseline form containing socioeconomic and demo-
graphic characteristics is completed. Outcomes are also
ascertained at 1, 3, and 6 months of age. At each of
these visits, child care practices, prevalence of illness,
and details of treatment-seeking and hospitalizations are
ascertained. Additionally, at the month 1 visit, informa-
tion is sought on whether any SSC was given and, if so,
the number of days and the number of hours each day
SSC was given by the mother or any other family mem-
ber. Weights and length measurements are taken using a
digital hanging weighing scale (AWS-SR-20; American
Weigh Scales, Cumming, GA, USA) and an infantometer
(model 417; Seca, Chino, CA, USA), respectively; head
circumference is measured with head-measuring tape
(model 212; Seca). At their scheduled visits, the outcome
ascertainment team also documents visits made by go-
vernment workers for all enrolled infants.
Verbal autopsies
A member of a separate team well trained in verbal
autopsy techniques visits each household as soon as pos-
sible after learning of the death of a study infant. A ver-
bal autopsy questionnaire is completed; this technique is
used to ascertain the cause of death [35]. An interview is
carried out with family members of the deceased infant
by using a structured questionnaire to elicit signs and
symptoms and other pertinent information, which are
used to assign the probable cause of death [35].
Process evaluation
Activities conducted by different teams are observed by
the process evaluation team. These include counseling
by the intervention delivery team, pregnancy surveil-
lance, pregnancy follow-up, screening and enrollment,
and anthropometric measurements. All main activities
and individual team members are covered. Feedback is
given to the person concerned, and corrective action is
taken if necessary.
Training and standardization of study teams
All staff were trained in study objectives, overall strategy,
and good clinical practice [36]. Each team underwent in-
tensive training pertaining to their work areas (e.g., preg-
nancy surveillance, door-to-door surveying, complete
documentation of household members, reporting preg-
nancies, and taking birth weights). The intervention de-
livery team was trained in counseling mothers in SSC
and in lactation support. They also visited hospitals with
KMC wards for hands-on practice sessions.
For the outcome measurement team, weight, length,
and head circumference inter- and intraobserver
standardization exercises were conducted before study
initiation and are repeated every 6 months. Weighing
scales and infantometers are calibrated periodically using
standard weights and length measurement rods.
Data management and monitoring
All data are captured electronically on phones or tablets.
Range and consistency checks are built in. Queries are
returned to the respective teams and resolved within 1
week of data collection. Data are transferred monthly to
the WHO for offsite data quality checks.
General principles for analysis
The primary analyses will be conducted on an intention-
to-treat basis. Analyses will be performed with both
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person time (infant years of follow-up, primary analysis)
and number of babies as the denominator. Random ef-
fects models and robust standard errors will be used to
account for clustering of deaths for twins, triplets, and
other study babies living in the same household. Data
cleaning will be completed and the databases locked be-
fore the data analysis workshop. The code will be broken
after the analysis has been carried out and we interpret
the findings, aiming to reduce the risk of prejudice.
Flow of participants
The flow and number of participants through assess-
ment of eligibility, randomization, follow-up, and ana-
lysis will be documented (Fig. 1). Reasons for exclusions
and withdrawals will be described.
Comparability of participants in the two groups
Summary values (means, proportions) for background
characteristics in the intervention and control groups
will be presented in a baseline table. These data will rep-
resent maternal age, parity, maternal education, wealth
index of the household, place of delivery, singleton or
multiple birth, sex of infant, birth weight, and age at en-
rollment. As per the Consolidated Standards of Report-
ing Trials (CONSORT) guidelines, we will not perform
significance tests to compare baseline characteristics be-
tween the study arms [37, 38]. Although our large sam-
ple size is likely to yield balance between the two study
arms in the main analyses, in our planned subgroup ana-
lyses, we will carefully evaluate the size of any baseline im-
balance. Imbalanced characteristics that predict death will
be appropriately adjusted for statistically.
Main effects
For the primary outcome (all-cause mortality between
enrollment and 28 days of age), data will first be ana-
lyzed using person time as the denominator. Hazard Ra-
tios (HRs) and 95% CIs will be calculated using a Cox
regression model to compare the effect of the interven-
tion (cKMC) with the control condition on infant
deaths. We will also estimate the effect of cKMC using
the number of enrolled infants as the denominator to
deduce risk ratios (RRs) using generalized linear models
(GLMs) of the binomial family with a log-link function.
Fig. 1 Participant flow through the study. KMC Kangaroo Mother Care
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However, if these regression models do not converge,
the delta method for nonlinear combinations of esti-
mated parameters from the coefficients computed in lo-
gistic regression shall be used [39]. The percentage
efficacy of the intervention will be calculated as (1 −
HR) × 100 and (1 − RR) × 100. To estimate the number
needed to treat, the reciprocal of the risk difference,
we will estimate the latter with a GLM of the bino-
mial family with an identity link. In the unlikely event
that there is imbalance between the intervention and
control groups, the final statistical models will include
appropriate statistical adjustment for all imbalanced
variables. The effect of cKMC on all-cause mortality
between enrollment and 180 days of age will be
assessed using the approaches outlined above.
The effect of KMC on secondary outcomes (exclu-
sive breastfeeding, weight, length gain, incidence of
important illnesses and hospitalizations, and care-
seeking) will be assessed using linear or logistic re-
gression, as appropriate, adjusting for clustering in
case of twins or another enrolled baby subsequently
born to the same woman, as well as other potential
confounders, and taking clustering into account as in
the primary analysis. Though an extended cost-
effectiveness analysis is planned, it is beyond the
scope of this paper and will be described in a sepa-
rate paper.
Subgroup analysis
We will undertake subgroup analyses for infants
according to birth weight categories, sex, timing of
initiation of KMC, and duration of KMC. The relative
measures of effect within each of these subgroups will
be estimated.
Data and safety monitoring committee
A DSMC has been constituted to review the data
twice a year with at least one face-to-face meeting
every year to monitor the progress of the trial and as-
sess the safety of the intervention. The members in-
clude an epidemiologist, a statistician a neonatologist
and an expert on community interventions. The
DSMC examines deaths, rate of enrollment and com-
pliance to the intervention every 6 months. An in-
terim analysis will be conducted when approximately
50% of the infants have been enrolled. This analysis
will be conducted in a blinded manner (treatment
groups X and Y). The randomization code shall be
broken following the recommendation of the DSMC
if there is clear evidence of a difference in mortality
between the two groups. The committee will advise
the study team on study continuation, modification or
termination based on preestablished stopping rules.
Study timeline
The study is running from July 2015 to September
2019 (Fig. 2).
Monitoring visits
Technical staff from the WHO interact with the study
team through conference calls and visits to the site to
review study progress. Monthly reports are shared by
the study team. All key areas are monitored; these
2015 2016 2017 2018 2019










1 month follow up
3 month follow up
6 month follow up
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure
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include the enrollment rate, timing of start of the inter-
vention delivery, consent procedures, follow-up visits,
and timely transmission of data to the WHO.
Discussion
This study will provide information on the impact of
KMC initiated at the community level. So far, the expe-
riences and documented benefits of KMC come from
hospital settings where KMC was initiated with the as-
sistance of skilled health workers. In a Cochrane review,
the studies were done in hospital settings, except for one
study conducted in the community in Bangladesh [28].
That community-initiated study found limited adoption
of KMC by mothers. Besides, birth weights were known
for only 60% of the babies. There was no measurable im-
pact of KMC on mortality. Therefore, the question
whether benefits of KMC seen in hospital settings can
be translated to settings where KMC is initiated in the
community in low- and middle-income countries re-
mains unanswered.
Formative research showed that cKMC was feasible
and acceptable, and high adoption rates were observed
in mothers of LBW babies. However, skilled counseling
was critical to resolve barriers and achieve these rates.
We feel that the initiation of KMC requires a worker
from a higher cadre (e.g., an ANM) than community-
level health workers such as ASHAs. The follow-up
support could be provided by ASHAs. In this trial,
therefore, local workers equivalent to government
ANMs were selected for initiation of the intervention.
Well-trained community health workers equivalent to
the government ASHAs provide follow-up support, with
the ANM visiting for problems. Because this is the first
time cKMC is being implemented in a community set-
ting, a design using well-trained study workers is consi-
dered to be most appropriate, owing to there being a
need to estimate the efficacy of the intervention.
On the basis of standard KMC guidelines, mothers
and other caregivers in this trial are advised to continue
KMC until 28 days of age or until the baby no longer
wants to stay in the KMC position [6, 33]. The primary
outcome is postenrollment neonatal mortality and post-
enrollment mortality until 6 months of age. Attempts
are made to initiate the intervention as soon as possible
after birth because a large proportion of the neonatal
mortality occurs within the first 24 h.
We believe that contamination between the mother-
infant pairs randomized to cKMC promotion and those
in the control families is unlikely. The households with
babies meeting the inclusion criteria are far away from
each other. Further, babies born in households where a
baby has previously been treated with KMC is not
randomized and will be provided KMC. Besides, we did
not encounter any resistance to the practice from
community members or health workers during formative
research, which would have necessitated the need for
community awareness generation activities. Because
promotion of cKMC requires hands-on demonstration,
intensive counseling, and high-level motivation, it is un-
likely that mothers or other family members will practice
KMC without adequate support.
Although it may be deemed that we are implementing
cKMC with high intensity in our trial, we believe that
the intervention is scalable in similar settings because
the workers delivering the intervention are similar in
terms of education and experience to their government-
employed counterparts. Moreover, there will be relatively
few babies who need KMC, so it should be possible to
manage them with the existing number of government
services. The process evaluation activities will provide
insights into barriers and facilitating factors. These will
be valuable sources of information for later scale-up and
adaptation to other settings.
Trial status
The trial is ongoing. Participant recruitment is expected
to be completed by mid-2019.
Additional file
Additional file 1: Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) checklist. (DOC 122 kb)
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